ISRG Intrinsic Value

Intrinsic Value of ISRG Overview

Key Highlights:
As of Mar 11, 2025 ISRG Relative Value is $179.0, which is overvalued by 63.7%, compared to current share price of $493.7.
As of Mar 11, 2025 ISRG DCF Value is $42.4, which is overvalued by 91.4%, compared to current share price of $493.7.
Methodology
Price per share, $
Current share price
493.7

ISRG Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

ISRG Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
20.3x (as of Mar 11, 2025)
EV/Gross Profit
30.1x (as of Mar 11, 2025)
EV/EBIT
72.2x (as of Mar 11, 2025)
EV/EBITDA
61.4x (as of Mar 11, 2025)
EV/FCF
130.1x (as of Mar 11, 2025)
EV/OCF
70.2x (as of Mar 11, 2025)
P/Revenue
20.8x (as of Mar 11, 2025)
P/Gross Profit
30.8x (as of Mar 11, 2025)
P/EBIT
73.9x (as of Mar 11, 2025)
P/EBITDA
62.9x (as of Mar 11, 2025)
P/FCF
133.2x (as of Mar 11, 2025)
P/OCF
71.9x (as of Mar 11, 2025)
P/E
74.8x (as of Mar 11, 2025)
P/BV
10.5x (as of Mar 11, 2025)
PEG 1Y
3.2x (as of Mar 11, 2025)

ISRG DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 ActualDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 EstimateDec'35 Terminal
% growth
4,358.4
(2.7%)
5,710.1
31.0%
6,222.2
9.0%
7,124.1
14.5%
8,352.1
17.2%
9,600.6
14.9%
11,098.1
15.6%
12,829.0
15.6%
14,677.1
14.4%
15,791.5
7.6%
16,869.6
6.8%
17,892.2
6.1%
18,839.8
5.3%
19,693.4
4.5%
20,435.0
3.8%
21,048.0
3.0%
773.6
17.7%
1,821.0
31.9%
1,211.3
19.5%
1,766.8
24.8%
2,348.9
28.1%
2,562.9
26.7%
2,962.6
26.7%
3,424.7
26.7%
3,918.0
26.7%
4,215.5
26.7%
4,503.3
26.7%
4,776.3
26.7%
5,029.3
26.7%
5,257.1
26.7%
5,455.1
26.7%
5,618.7
26.7%
NOPAT
% effective tax rate
683.7
15.7%
1,664.7
29.2%
1,013.5
16.3%
1,639.1
23.0%
2,053.5
24.6%
2,240.5
23.3%
2,590.0
23.3%
2,993.9
23.3%
3,425.2
23.3%
3,685.3
23.3%
3,936.9
23.3%
4,175.6
23.3%
4,396.7
23.3%
4,595.9
23.3%
4,769.0
23.3%
4,912.0
23.3%
% of revenue
282.5
6.5%
317.0
5.6%
380.4
6.1%
421.8
5.9%
324.9
3.9%
509.6
5.3%
589.1
5.3%
681.0
5.3%
779.1
5.3%
838.2
5.3%
895.5
5.3%
949.7
5.3%
1,000.0
5.3%
1,045.4
5.3%
1,084.7
5.3%
1,117.3
5.3%
% of revenue
(341.5)
(7.8%)
(353.5)
(6.2%)
(532.4)
(8.6%)
(1,064.2)
(14.9%)
(1,111.2)
(13.3%)
(1,177.6)
(12.3%)
(1,361.3)
(12.3%)
(1,573.6)
(12.3%)
(1,800.3)
(12.3%)
(1,937.0)
(12.3%)
(2,069.3)
(12.3%)
(2,194.7)
(12.3%)
(2,310.9)
(12.3%)
(2,415.7)
(12.3%)
(2,506.6)
(12.3%)
(2,581.8)
(12.3%)
(273.2)
(6.3%)
(368.1)
(6.4%)
(619.1)
(9.9%)
(777.6)
(10.9%)
(919.3)
(11.0%)
(1,020.0)
(10.6%)
(1,179.0)
(10.6%)
(1,362.9)
(10.6%)
(1,559.3)
(10.6%)
(1,677.7)
(10.6%)
(1,792.2)
(10.6%)
(1,900.9)
(10.6%)
(2,001.5)
(10.6%)
(2,092.2)
(10.6%)
(2,171.0)
(10.6%)
(2,236.1)
(10.6%)
Free Cash Flow to Firm (FCFF)
% of revenue
351.5
8.1%
1,260.1
22.1%
242.4
3.9%
219.1
3.1%
347.9
4.2%
552.5
5.8%
638.7
5.8%
738.3
5.8%
844.7
5.8%
908.8
5.8%
970.9
5.8%
1,029.7
5.8%
1,084.3
5.8%
1,133.4
5.8%
1,176.1
5.8%
1,211.4
5.8%
% of FCFF used in calculation
80.8%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Discount period
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
9.50
Discount factor
0.95
0.86
0.77
0.70
0.63
0.57
0.51
0.46
0.42
0.38
Discounted FCFF (DFCFF)
424.1
547.2
570.7
589.0
571.6
550.9
527.1
500.6
472.1
441.9

ISRG DCF Value

DCF Value Calculation

as of Mar 11, 2025
Sum of DFCFF
% share of EV
5,195.2M
47.3%
Terminal Value (TV)
15.4B
Discounted TV
% share of EV
5,795.6M
52.7%
Total Debt
0.0
Shares outstanding
351.7M
FX rate
1.0
91.4% overvalued

Equity Value Bridge

ISRG Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

ISRG Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
3.0%
FX rate
1.0
Last share price
522.0
Implied FCF growth 1-10Y
36.9%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with ISRG Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$173.6B
$169.6B
$111.9
77.3% overvalued
$42.7
91.0% overvalued
$181.2
63.3% overvalued
$168.9
65.8% overvalued
$134.4
72.8% overvalued
10.1%
89.9%
36.9%
44.4%
$65.1B
$83.1B
$270.4
20.2% undervalued
$192.6
14.0% overvalued
$348.2
54.8% undervalued
$9.1
95.9% overvalued
$387.2
72.1% undervalued
46.1%
53.9%
(2.3%)
(3.1%)
$43.8B
$47.1B
$60.2
32.5% overvalued
$26.2
71.0% overvalued
$94.2
5.6% undervalued
$116.9
31.1% undervalued
$75.0
15.9% overvalued
34.0%
66.0%
19.2%
15.4%
$33.7B
$34.0B
$193.3
14.4% overvalued
$142.2
37.0% overvalued
$244.4
8.2% undervalued
$321.8
42.5% undervalued
$198.7
12.0% overvalued
48.0%
52.0%
4.0%
4.0%
$18.4B
$30.1B
$61.4
71.3% undervalued
Negative
121.0% overvalued
$61.4
71.3% undervalued
$549.1
1,431.7% undervalued
N/A
(14.4%)
114.4%
(8.6%)
(7.4%)
$16.7B
$16.5B
$144.5
37.4% overvalued
$92.6
60.0% overvalued
$196.5
14.9% overvalued
Negative
106.8% overvalued
$16.1
93.0% overvalued
20.9%
79.1%
25.3%
23.2%
$15.9B
$18.3B
$101.3
25.0% undervalued
Negative
105.0% overvalued
$101.3
25.0% undervalued
$195.4
141.2% undervalued
$105.8
30.5% undervalued
27.1%
72.9%
18.5%
19.9%
$14.5B
$12.6B
$129.4
106.8% undervalued
$122.6
96.0% undervalued
$136.3
117.8% undervalued
$93.9
50.0% undervalued
$57.2
8.6% overvalued
56.1%
43.9%
(2.0%)
(1.6%)
$9,861.6M
$10.3B
$172.1
16.4% undervalued
$112.7
24.0% overvalued
$231.5
56.5% undervalued
$26.9
81.8% overvalued
$35.3
76.2% overvalued
50.6%
49.4%
4.7%
4.6%
$8,911.5M
$9,461.8M
$75.8
54.5% overvalued
$34.0
80.0% overvalued
$117.7
29.3% overvalued
$899.8
440.4% undervalued
N/A
(31.3%)
131.3%
18.9%
19.6%
$8,018.4M
$8,018.4M
$72.7
50.6% overvalued
$85.0
42.0% overvalued
$60.3
59.0% overvalued
$72.0
51.1% overvalued
N/A
(7.4%)
107.4%
19.0%
17.8%

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.

FAQ

What is the DCF value of Intuitive Surgical, Inc. (ISRG)?

As of today, DCF Value of Intuitive Surgical, Inc. is $42.7, which is overvalued by 91.4%, compared to the current market share price of $493.7

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating Intuitive Surgical, Inc. future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $0.0B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 0 to determine DCF Value of $42.7

What is the Relative value of Intuitive Surgical, Inc. (ISRG)?

As of today, Relative Value of Intuitive Surgical, Inc. is $181.2, which is overvalued by 63.3%, compared to the current market share price of $493.7

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to Intuitive Surgical, Inc. financials to determine Relative Value of $181.2

What is Intuitive Surgical, Inc. (ISRG) discount rate?

Intuitive Surgical, Inc. current Cost of Equity is 10.9%, while its WACC stands at 10.9%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for Intuitive Surgical, Inc. (ISRG) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 10.9% = 4.3% + 1.4 x 4.6%

How is WACC for Intuitive Surgical, Inc. (ISRG) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company's entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 10.9% = 10.9% x 0.0% + 0.0% x (1 - 15.0%) x 100.0%